FDA calendar: PDUFA dates and approval decisions

Upcoming PDUFA dates disclosed by companies, plus FDA approval decisions, complete response letters and advisory committee meetings. Every entry links to its drug and to the SEC filing or FDA record it came from. Subscribe to the calendar feed (.ics) or get upcoming dates by email each week.

Filters
Clear filters

1463 matching events. Showing the first 200; search or set a date range to see the rest. Partial dates are included when their reported period overlaps your range; undisclosed dates have their own view.

Date as reportedDrug / companyEventConditionEvidence
1953-07-27DayAcetazolamideFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA008943", "applicant_as_listed_by_fda": "TEVA BRANDED PHARM", "brand_names": ["DIAMOX"], "active_ingredients": ["ACETAZOLAMIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19530727", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

1955-04-18DayHydroxychloroquineFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA009768", "applicant_as_listed_by_fda": "ADVANZ PHARMA", "brand_names": ["PLAQUENIL"], "active_ingredients": ["HYDROXYCHLOROQUINE SULFATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19550418", "matched_on": "registry alias equals FDA brand name and drug name is its active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

1957-03-18DayChlorambucilFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA010669", "applicant_as_listed_by_fda": "WAYLIS THERAP", "brand_names": ["LEUKERAN"], "active_ingredients": ["CHLORAMBUCIL"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19570318", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

1957-10-24DayMethylprednisoloneFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA011153", "applicant_as_listed_by_fda": "PFIZER", "brand_names": ["MEDROL"], "active_ingredients": ["METHYLPREDNISOLONE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19571024", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

1958-10-30DayDexamethasoneFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA011664", "applicant_as_listed_by_fda": "MERCK", "brand_names": ["DECADRON"], "active_ingredients": ["DEXAMETHASONE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19581030", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

1959-11-16DayCyclophosphamideFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA012141", "applicant_as_listed_by_fda": "BAXTER HLTHCARE", "brand_names": ["CYTOXAN"], "active_ingredients": ["CYCLOPHOSPHAMIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19591116", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

1962-04-25DayFluorouracilFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA012209", "applicant_as_listed_by_fda": "SPECTRUM PHARMS", "brand_names": ["FLUOROURACIL"], "active_ingredients": ["FLUOROURACIL"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19620425", "matched_on": "drug name equals FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

1969-06-17DayCytarabineFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA016793", "applicant_as_listed_by_fda": "TEVA PARENTERAL", "brand_names": ["CYTARABINE"], "active_ingredients": ["CYTARABINE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19690617", "matched_on": "drug name equals FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

1975-05-27DayDacarbazineFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA017575", "applicant_as_listed_by_fda": "BAYER HLTHCARE", "brand_names": ["DTIC-DOME"], "active_ingredients": ["DACARBAZINE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19750527", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

1976-08-04DayLomustineFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA017588", "applicant_as_listed_by_fda": "AZURITY", "brand_names": ["GLEOSTINE"], "active_ingredients": ["LOMUSTINE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19760804", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

1978-12-19DayCisplatinFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA018057", "applicant_as_listed_by_fda": "HQ SPCLT PHARMA", "brand_names": ["CISPLATIN", "PLATINOL", "PLATINOL-AQ"], "active_ingredients": ["CISPLATIN"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19781219", "matched_on": "drug name equals FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

1979-12-19DayDaunorubicinFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA050484", "applicant_as_listed_by_fda": "WYETH AYERST", "brand_names": ["CERUBIDINE"], "active_ingredients": ["DAUNORUBICIN HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19791219", "matched_on": "registry alias equals FDA brand name and drug name is its active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

1980-04-10DayTrifluridineFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA018299", "applicant_as_listed_by_fda": "MONARCH PHARMS", "brand_names": ["VIROPTIC"], "active_ingredients": ["TRIFLURIDINE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19800410", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

1985-05-31DayDronabinolFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA018651", "applicant_as_listed_by_fda": "ALKEM LABS LTD", "brand_names": ["MARINOL"], "active_ingredients": ["DRONABINOL"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19850531", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

1986-10-16DaySomatropinFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA019640", "applicant_as_listed_by_fda": "LILLY", "brand_names": ["HUMATROPE"], "active_ingredients": ["SOMATROPIN"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19861016", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

1989-03-03DayCarboplatinFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA019880", "applicant_as_listed_by_fda": "CORDEN PHARMA", "brand_names": ["PARAPLATIN"], "active_ingredients": ["CARBOPLATIN"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19890303", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

1989-12-29DaygoserelinFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA019726", "applicant_as_listed_by_fda": "TERSERA", "brand_names": ["ZOLADEX"], "active_ingredients": ["GOSERELIN ACETATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19891229", "matched_on": "registry alias equals FDA brand name and drug name is its active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

1990-01-29DayFluconazoleFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA019949", "applicant_as_listed_by_fda": "PFIZER", "brand_names": ["DIFLUCAN"], "active_ingredients": ["FLUCONAZOLE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19900129", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

1990-09-27DayIdarubicinFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA050661", "applicant_as_listed_by_fda": "PFIZER", "brand_names": ["IDAMYCIN"], "active_ingredients": ["IDARUBICIN HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19900927", "matched_on": "registry alias equals FDA brand name and drug name is its active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

1991-04-18DayFludarabineFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA020038", "applicant_as_listed_by_fda": "GENZYME CORP", "brand_names": ["FLUDARA"], "active_ingredients": ["FLUDARABINE PHOSPHATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19910418", "matched_on": "registry alias equals FDA brand name and drug name is its active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

1991-12-09DayOnabotulinumtoxinAFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA103000", "applicant_as_listed_by_fda": "ALLERGAN", "brand_names": ["BOTOX", "BOTOX COSMETIC"], "active_ingredients": ["OnabotulinumtoxinA"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19911209", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

1992-12-29DayPaclitaxelFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA020262", "applicant_as_listed_by_fda": "HQ SPCLT PHARMA", "brand_names": ["TAXOL"], "active_ingredients": ["PACLITAXEL"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19921229", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

1993-12-29DayrisperidoneFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA020272", "applicant_as_listed_by_fda": "JANSSEN PHARMS", "brand_names": ["RISPERDAL"], "active_ingredients": ["RISPERIDONE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19931229", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

1994-04-08DayTacrolimusFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA050708", "applicant_as_listed_by_fda": "ASTELLAS", "brand_names": ["PROGRAF"], "active_ingredients": ["TACROLIMUS"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19940408", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

1994-12-23DayVinorelbineFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA020388", "applicant_as_listed_by_fda": "PIERRE FABRE", "brand_names": ["NAVELBINE"], "active_ingredients": ["VINORELBINE TARTRATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19941223", "matched_on": "registry alias equals FDA brand name and drug name is its active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

1995-06-23DayValacyclovirFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA020487", "applicant_as_listed_by_fda": "GLAXOSMITHKLINE", "brand_names": ["VALTREX"], "active_ingredients": ["VALACYCLOVIR HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19950623", "matched_on": "registry alias equals FDA brand name and drug name is its active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

1995-12-27DayAnastrozoleFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA020541", "applicant_as_listed_by_fda": "ANI PHARMS", "brand_names": ["ARIMIDEX"], "active_ingredients": ["ANASTROZOLE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19951227", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

1996-05-14DayDocetaxelFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA020449", "applicant_as_listed_by_fda": "SANOFI AVENTIS US", "brand_names": ["TAXOTERE"], "active_ingredients": ["DOCETAXEL"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19960514", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

1996-05-14DaydocetaxelFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA020449", "applicant_as_listed_by_fda": "SANOFI AVENTIS US", "brand_names": ["TAXOTERE"], "active_ingredients": ["DOCETAXEL"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19960514", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

1996-05-15DayGemcitabineFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA020509", "applicant_as_listed_by_fda": "LILLY", "brand_names": ["GEMZAR"], "active_ingredients": ["GEMCITABINE HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19960515", "matched_on": "registry alias equals FDA brand name and drug name is its active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

1996-05-28DayTopotecanFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA020671", "applicant_as_listed_by_fda": "SANDOZ", "brand_names": ["HYCAMTIN"], "active_ingredients": ["TOPOTECAN HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19960528", "matched_on": "registry alias equals FDA brand name and drug name is its active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

1996-06-14DayIrinotecanFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA020571", "applicant_as_listed_by_fda": "PFIZER INC", "brand_names": ["CAMPTOSAR"], "active_ingredients": ["IRINOTECAN HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19960614", "matched_on": "registry alias equals FDA brand name and drug name is its active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

1996-09-30DayOlanzapineFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA020592", "applicant_as_listed_by_fda": "CHEPLAPHARM", "brand_names": ["ZYPREXA"], "active_ingredients": ["OLANZAPINE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19960930", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

1996-09-30DayolanzapineFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA020592", "applicant_as_listed_by_fda": "CHEPLAPHARM", "brand_names": ["ZYPREXA"], "active_ingredients": ["OLANZAPINE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19960930", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

1997-07-25DayLetrozoleFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA020726", "applicant_as_listed_by_fda": "NOVARTIS PHARMS", "brand_names": ["FEMARA"], "active_ingredients": ["LETROZOLE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19970725", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

1997-09-30DayIrbesartanFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA020757", "applicant_as_listed_by_fda": "SANOFI AVENTIS US", "brand_names": ["AVAPRO"], "active_ingredients": ["IRBESARTAN"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19970930", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

1997-09-30DayirbesartanFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA020757", "applicant_as_listed_by_fda": "SANOFI AVENTIS US", "brand_names": ["AVAPRO"], "active_ingredients": ["IRBESARTAN"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19970930", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

1997-11-26DayRituximabFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA103705", "applicant_as_listed_by_fda": "GENENTECH", "brand_names": ["RITUXAN"], "active_ingredients": ["RITUXIMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19971126", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

1997-11-26DayrituximabFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA103705", "applicant_as_listed_by_fda": "GENENTECH", "brand_names": ["RITUXAN"], "active_ingredients": ["RITUXIMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19971126", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

1997-12-22DayRepaglinideFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA020741", "applicant_as_listed_by_fda": "GEMINI LABS LLC", "brand_names": ["PRANDIN"], "active_ingredients": ["REPAGLINIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19971222", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 19 Oct 2026 · Evidence last checked: 19 Oct 2026

1998-04-30DayCapecitabineFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA020896", "applicant_as_listed_by_fda": "CHEPLAPHARM", "brand_names": ["XELODA"], "active_ingredients": ["CAPECITABINE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19980430", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

1998-09-25DayTrastuzumabFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA103792", "applicant_as_listed_by_fda": "GENENTECH", "brand_names": ["HERCEPTIN"], "active_ingredients": ["TRASTUZUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19980925", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

1999-08-11DayTemozolomideFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA021029", "applicant_as_listed_by_fda": "MERCK SHARP DOHME", "brand_names": ["TEMODAR"], "active_ingredients": ["TEMOZOLOMIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19990811", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

1999-10-21DayExemestaneFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA020753", "applicant_as_listed_by_fda": "PFIZER", "brand_names": ["AROMASIN"], "active_ingredients": ["EXEMESTANE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19991021", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2000-04-13DayMeloxicamFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA020938", "applicant_as_listed_by_fda": "BOEHRINGER INGELHEIM", "brand_names": ["MOBIC"], "active_ingredients": ["MELOXICAM"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20000413", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2000-06-07DayNovoLogFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA020986", "applicant_as_listed_by_fda": "NOVO NORDISK INC", "brand_names": ["NOVOLOG", "NOVOLOG FLEXPEN", "NOVOLOG FLEXTOUCH", "NOVOLOG INNOLET", "NOVOLOG PENFILL"], "active_ingredients": ["INSULIN ASPART RECOMBINANT"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20000607", "matched_on": "drug name equals FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2001-03-16DayTravoprostFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA021257", "applicant_as_listed_by_fda": "ALCON PHARMS LTD", "brand_names": ["TRAVATAN"], "active_ingredients": ["TRAVOPROST"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20010316", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2001-09-17DayDarbepoetin alfaFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA103951", "applicant_as_listed_by_fda": "AMGEN", "brand_names": ["ARANESP"], "active_ingredients": ["DARBEPOETIN ALFA"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20010917", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2001-10-26Daytenofovir disoproxilFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA021356", "applicant_as_listed_by_fda": "GILEAD SCIENCES INC", "brand_names": ["VIREAD"], "active_ingredients": ["TENOFOVIR DISOPROXIL FUMARATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20011026", "matched_on": "registry alias equals FDA brand name and drug name is its active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2001-10-26DayTenofovirFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA021356", "applicant_as_listed_by_fda": "GILEAD SCIENCES INC", "brand_names": ["VIREAD"], "active_ingredients": ["TENOFOVIR DISOPROXIL FUMARATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20011026", "matched_on": "registry alias equals FDA brand name and drug name is its active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2002-01-31DayPegfilgrastimFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA125031", "applicant_as_listed_by_fda": "AMGEN", "brand_names": ["NEULASTA"], "active_ingredients": ["PEGFILGRASTIM"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20020131", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2002-04-25DayFulvestrantFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA021344", "applicant_as_listed_by_fda": "ASTRAZENECA", "brand_names": ["FASLODEX"], "active_ingredients": ["FULVESTRANT"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20020425", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2002-05-24DayVoriconazoleFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA021266", "applicant_as_listed_by_fda": "PF PRISM CV", "brand_names": ["VFEND"], "active_ingredients": ["VORICONAZOLE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20020524", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2002-08-09DayOxaliplatinFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA021492", "applicant_as_listed_by_fda": "SANOFI AVENTIS US", "brand_names": ["ELOXATIN"], "active_ingredients": ["OXALIPLATIN"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20020809", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2002-11-15DayaripiprazoleFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA021436", "applicant_as_listed_by_fda": "OTSUKA", "brand_names": ["ABILIFY"], "active_ingredients": ["ARIPIPRAZOLE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20021115", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2002-11-26DayAtomoxetine HydrochlorideFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA021411", "applicant_as_listed_by_fda": "LILLY", "brand_names": ["STRATTERA"], "active_ingredients": ["ATOMOXETINE HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20021126", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2002-12-31DayAdalimumabFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA125057", "applicant_as_listed_by_fda": "ABBVIE INC", "brand_names": ["HUMIRA"], "active_ingredients": ["ADALIMUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20021231", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2003-05-13DayBortezomibFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA021602", "applicant_as_listed_by_fda": "TAKEDA PHARMS USA", "brand_names": ["VELCADE"], "active_ingredients": ["BORTEZOMIB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20030513", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2004-02-04DayPemetrexedFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA021462", "applicant_as_listed_by_fda": "LILLY", "brand_names": ["ALIMTA"], "active_ingredients": ["PEMETREXED DISODIUM"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20040204", "matched_on": "registry alias equals FDA brand name and drug name is its active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2004-02-12DaycetuximabFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA125084", "applicant_as_listed_by_fda": "IMCLONE", "brand_names": ["ERBITUX"], "active_ingredients": ["CETUXIMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20040212", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2004-02-12DayCetuximabFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA125084", "applicant_as_listed_by_fda": "IMCLONE", "brand_names": ["ERBITUX"], "active_ingredients": ["CETUXIMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20040212", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2004-02-26DaybevacizumabFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA125085", "applicant_as_listed_by_fda": "GENENTECH", "brand_names": ["AVASTIN"], "active_ingredients": ["BEVACIZUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20040226", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2004-02-26DayBevacizumabFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA125085", "applicant_as_listed_by_fda": "GENENTECH", "brand_names": ["AVASTIN"], "active_ingredients": ["BEVACIZUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20040226", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2004-05-19DayAzacitidineFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA050794", "applicant_as_listed_by_fda": "BRISTOL-MYERS", "brand_names": ["VIDAZA"], "active_ingredients": ["AZACITIDINE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20040519", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2004-11-18DayErlotinibFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA021743", "applicant_as_listed_by_fda": "OSI PHARMS", "brand_names": ["TARCEVA"], "active_ingredients": ["ERLOTINIB HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20041118", "matched_on": "registry alias equals FDA brand name and drug name is its active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2005-03-29DayentecavirFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA021797", "applicant_as_listed_by_fda": "BRISTOL MYERS SQUIBB", "brand_names": ["BARACLUDE"], "active_ingredients": ["ENTECAVIR"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20050329", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2005-03-29DayEntecavirFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA021797", "applicant_as_listed_by_fda": "BRISTOL MYERS SQUIBB", "brand_names": ["BARACLUDE"], "active_ingredients": ["ENTECAVIR"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20050329", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2005-12-01DaySorafenibFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA021923", "applicant_as_listed_by_fda": "BAYER HLTHCARE", "brand_names": ["NEXAVAR"], "active_ingredients": ["SORAFENIB TOSYLATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20051201", "matched_on": "registry alias equals FDA brand name and drug name is its active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2005-12-27DayLenalidomideFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA021880", "applicant_as_listed_by_fda": "BRISTOL MYERS SQUIBB", "brand_names": ["REVLIMID"], "active_ingredients": ["LENALIDOMIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20051227", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2006-01-26DaySunitinib MalateFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA021938", "applicant_as_listed_by_fda": "CPPI CV", "brand_names": ["SUTENT"], "active_ingredients": ["SUNITINIB MALATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20060126", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2006-05-02DayDecitabineFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA021790", "applicant_as_listed_by_fda": "OTSUKA", "brand_names": ["DACOGEN"], "active_ingredients": ["DECITABINE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20060502", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2006-06-30DayranibizumabFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA125156", "applicant_as_listed_by_fda": "GENENTECH", "brand_names": ["LUCENTIS"], "active_ingredients": ["RANIBIZUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20060630", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2006-07-24DayidursulfaseFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA125151", "applicant_as_listed_by_fda": "SHIRE", "brand_names": ["ELAPRASE"], "active_ingredients": ["IDURSULFASE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20060724", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2006-09-27DaypanitumumabFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA125147", "applicant_as_listed_by_fda": "AMGEN", "brand_names": ["VECTIBIX"], "active_ingredients": ["PANITUMUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20060927", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2007-03-16DayEculizumabFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA125166", "applicant_as_listed_by_fda": "ALEXION PHARM", "brand_names": ["SOLIRIS"], "active_ingredients": ["ECULIZUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20070316", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2007-10-19DaySevelamer CarbonateFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA022127", "applicant_as_listed_by_fda": "SANOFI", "brand_names": ["RENVELA"], "active_ingredients": ["SEVELAMER CARBONATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20071019", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2007-11-14DayMircera®FDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA125164", "applicant_as_listed_by_fda": "HOFFMAN-LA ROCHE", "brand_names": ["MIRCERA"], "active_ingredients": ["METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20071114", "matched_on": "drug name equals FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2008-02-27DayRilonaceptFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA125249", "applicant_as_listed_by_fda": "KINIKSA PHARMACEUTICALS (UK), LTD.", "brand_names": ["ARCALYST"], "active_ingredients": ["RILONACEPT"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20080227", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2009-03-30DayEverolimusFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA022334", "applicant_as_listed_by_fda": "NOVARTIS", "brand_names": ["AFINITOR"], "active_ingredients": ["EVEROLIMUS"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20090330", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2009-05-06DayIloperidoneFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA022192", "applicant_as_listed_by_fda": "VANDA PHARMS INC", "brand_names": ["FANAPT"], "active_ingredients": ["ILOPERIDONE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20090506", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2009-05-06DayiloperidoneFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA022192", "applicant_as_listed_by_fda": "VANDA PHARMS INC", "brand_names": ["FANAPT"], "active_ingredients": ["ILOPERIDONE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20090506", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2009-09-24DayPralatrexateFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA022468", "applicant_as_listed_by_fda": "ACROTECH BIOPHARMA", "brand_names": ["FOLOTYN"], "active_ingredients": ["PRALATREXATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20090924", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2010-11-15DayEribulinFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA201532", "applicant_as_listed_by_fda": "EISAI INC", "brand_names": ["HALAVEN"], "active_ingredients": ["ERIBULIN MESYLATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20101115", "matched_on": "registry alias equals FDA brand name and drug name is its active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2011-03-25DayIpilimumabFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA125377", "applicant_as_listed_by_fda": "BRISTOL MYERS SQUIBB", "brand_names": ["YERVOY"], "active_ingredients": ["IPILIMUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20110325", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2011-04-28DayabirateroneFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA202379", "applicant_as_listed_by_fda": "JANSSEN BIOTECH", "brand_names": ["ZYTIGA"], "active_ingredients": ["ABIRATERONE ACETATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20110428", "matched_on": "registry alias equals FDA brand name and drug name is its active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2011-04-28DayAbiraterone AcetateFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA202379", "applicant_as_listed_by_fda": "JANSSEN BIOTECH", "brand_names": ["ZYTIGA"], "active_ingredients": ["ABIRATERONE ACETATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20110428", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2011-08-26DayCrizotinibFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA202570", "applicant_as_listed_by_fda": "PF PRISM CV", "brand_names": ["XALKORI"], "active_ingredients": ["CRIZOTINIB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20110826", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2011-11-16DayRuxolitinibFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA202192", "applicant_as_listed_by_fda": "INCYTE CORP", "brand_names": ["JAKAFI"], "active_ingredients": ["RUXOLITINIB PHOSPHATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20111116", "matched_on": "registry alias equals FDA brand name and drug name is its active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2011-11-18DayAfliberceptFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA125387", "applicant_as_listed_by_fda": "REGENERON PHARMACEUTICALS", "brand_names": ["EYLEA"], "active_ingredients": ["AFLIBERCEPT"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20111118", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2012-01-31DayIvacaftorFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA203188", "applicant_as_listed_by_fda": "VERTEX PHARMS", "brand_names": ["KALYDECO"], "active_ingredients": ["IVACAFTOR"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20120131", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2012-06-08DayPertuzumabFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA125409", "applicant_as_listed_by_fda": "GENENTECH", "brand_names": ["PERJETA"], "active_ingredients": ["PERTUZUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20120608", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2012-08-31DayEnzalutamideFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA203415", "applicant_as_listed_by_fda": "ASTELLAS", "brand_names": ["XTANDI"], "active_ingredients": ["ENZALUTAMIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20120831", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2012-09-27DayRegorafenibFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA203085", "applicant_as_listed_by_fda": "BAYER HLTHCARE", "brand_names": ["STIVARGA"], "active_ingredients": ["REGORAFENIB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20120927", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2013-05-29DayTrametinibFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA204114", "applicant_as_listed_by_fda": "NOVARTIS", "brand_names": ["MEKINIST"], "active_ingredients": ["TRAMETINIB DIMETHYL SULFOXIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20130529", "matched_on": "registry alias equals FDA brand name and drug name is its active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2013-11-01DayObinutuzumabFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA125486", "applicant_as_listed_by_fda": "GENENTECH", "brand_names": ["GAZYVA"], "active_ingredients": ["OBINUTUZUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20131101", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2013-11-01DayobinutuzumabFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA125486", "applicant_as_listed_by_fda": "GENENTECH", "brand_names": ["GAZYVA"], "active_ingredients": ["OBINUTUZUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20131101", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 26 Oct 2026 · Evidence last checked: 26 Oct 2026

2013-11-13DayIbrutinibFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA205552", "applicant_as_listed_by_fda": "PHARMACYCLICS LLC", "brand_names": ["IMBRUVICA"], "active_ingredients": ["IBRUTINIB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20131113", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2014-01-08DayDapagliflozinFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA202293", "applicant_as_listed_by_fda": "ASTRAZENECA AB", "brand_names": ["FARXIGA"], "active_ingredients": ["DAPAGLIFLOZIN"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20140108", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2014-01-31DayTasimelteonFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA205677", "applicant_as_listed_by_fda": "VANDA PHARMS INC", "brand_names": ["HETLIOZ"], "active_ingredients": ["TASIMELTEON"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20140131", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2014-01-31DaytasimelteonFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA205677", "applicant_as_listed_by_fda": "VANDA PHARMS INC", "brand_names": ["HETLIOZ"], "active_ingredients": ["TASIMELTEON"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20140131", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2014-03-21DayApremilastFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA205437", "applicant_as_listed_by_fda": "AMGEN INC", "brand_names": ["OTEZLA"], "active_ingredients": ["APREMILAST"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20140321", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2014-04-21DayRamucirumabFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA125477", "applicant_as_listed_by_fda": "ELI LILLY AND CO", "brand_names": ["CYRAMZA"], "active_ingredients": ["RAMUCIRUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20140421", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2014-05-20DayVedolizumabFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA125476", "applicant_as_listed_by_fda": "TAKEDA PHARMS USA", "brand_names": ["ENTYVIO"], "active_ingredients": ["VEDOLIZUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20140520", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2014-06-27DayAfrezzaFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA022472", "applicant_as_listed_by_fda": "MANNKIND", "brand_names": ["AFREZZA"], "active_ingredients": ["INSULIN RECOMBINANT HUMAN"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20140627", "matched_on": "drug name equals FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2014-07-03DayBelinostatFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA206256", "applicant_as_listed_by_fda": "ACROTECH BIOPHARMA", "brand_names": ["BELEODAQ"], "active_ingredients": ["BELINOSTAT"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20140703", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2014-09-04DayPembrolizumabFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA125514", "applicant_as_listed_by_fda": "MERCK SHARP DOHME", "brand_names": ["KEYTRUDA"], "active_ingredients": ["PEMBROLIZUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20140904", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2014-09-04DaypembrolizumabFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA125514", "applicant_as_listed_by_fda": "MERCK SHARP DOHME", "brand_names": ["KEYTRUDA"], "active_ingredients": ["PEMBROLIZUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20140904", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2014-12-19DayOlaparibFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA206162", "applicant_as_listed_by_fda": "ASTRAZENECA", "brand_names": ["LYNPARZA"], "active_ingredients": ["OLAPARIB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20141219", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2014-12-22DayNivolumabFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA125554", "applicant_as_listed_by_fda": "BRISTOL MYERS SQUIBB", "brand_names": ["OPDIVO"], "active_ingredients": ["NIVOLUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20141222", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2014-12-22DaynivolumabFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA125554", "applicant_as_listed_by_fda": "BRISTOL MYERS SQUIBB", "brand_names": ["OPDIVO"], "active_ingredients": ["NIVOLUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20141222", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-01-07DayRYTARYFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA203312", "applicant_as_listed_by_fda": "IMPAX", "brand_names": ["RYTARY"], "active_ingredients": ["CARBIDOPA", "LEVODOPA"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150107", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-01-08DaySAVAYSAFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA206316", "applicant_as_listed_by_fda": "DAIICHI SANKYO INC", "brand_names": ["SAVAYSA"], "active_ingredients": ["EDOXABAN TOSYLATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150108", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-01-09DayDUOPAFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA203952", "applicant_as_listed_by_fda": "ABBVIE", "brand_names": ["DUOPA"], "active_ingredients": ["CARBIDOPA", "LEVODOPA"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150109", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-01-13DayPHOXILLUM BK 4/2.5 IN PLASTIC CONTAINERFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA207026", "applicant_as_listed_by_fda": "VANTIVE US HLTHCARE", "brand_names": ["PHOXILLUM B22K 4/0 IN PLASTIC CONTAINER", "PHOXILLUM BK 4/2.5 IN PLASTIC CONTAINER"], "active_ingredients": ["CALCIUM CHLORIDE", "MAGNESIUM CHLORIDE", "POTASSIUM CHLORIDE", "SODIUM BICARBONATE", "SODIUM CHLORIDE", "SODIUM PHOSPHATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150113", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-01-13DayPHOXILLUM B22K 4/0 IN PLASTIC CONTAINERFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA207026", "applicant_as_listed_by_fda": "VANTIVE US HLTHCARE", "brand_names": ["PHOXILLUM B22K 4/0 IN PLASTIC CONTAINER", "PHOXILLUM BK 4/2.5 IN PLASTIC CONTAINER"], "active_ingredients": ["CALCIUM CHLORIDE", "MAGNESIUM CHLORIDE", "POTASSIUM CHLORIDE", "SODIUM BICARBONATE", "SODIUM CHLORIDE", "SODIUM PHOSPHATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150113", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-01-21DayPRESTALIAFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA205003", "applicant_as_listed_by_fda": "ADHERA", "brand_names": ["PRESTALIA"], "active_ingredients": ["AMLODIPINE BESYLATE", "PERINDOPRIL ARGININE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150121", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-01-21DayCOSENTYXFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA125504", "applicant_as_listed_by_fda": "NOVARTIS PHARMS CORP", "brand_names": ["COSENTYX"], "active_ingredients": ["SECUKINUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150121", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-01-23DayTRIFERICFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA206317", "applicant_as_listed_by_fda": "ROCKWELL MEDICAL INC", "brand_names": ["TRIFERIC"], "active_ingredients": ["FERRIC PYROPHOSPHATE CITRATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150123", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-01-23DayNATPARAFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA125511", "applicant_as_listed_by_fda": "NPS PHARMS INC", "brand_names": ["NATPARA"], "active_ingredients": ["PARATHYROID HORMONE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150123", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-01-29DayEVOTAZFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA206353", "applicant_as_listed_by_fda": "BRISTOL", "brand_names": ["EVOTAZ"], "active_ingredients": ["ATAZANAVIR SULFATE", "COBICISTAT"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150129", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-01-30DayGLYXAMBIFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA206073", "applicant_as_listed_by_fda": "BOEHRINGER INGELHEIM", "brand_names": ["GLYXAMBI"], "active_ingredients": ["EMPAGLIFLOZIN", "LINAGLIPTIN"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150130", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-02-03DayPalbociclibFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA207103", "applicant_as_listed_by_fda": "PFIZER", "brand_names": ["IBRANCE"], "active_ingredients": ["PALBOCICLIB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150203", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-02-03DayIBRANCEFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA207103", "applicant_as_listed_by_fda": "PFIZER", "brand_names": ["IBRANCE"], "active_ingredients": ["PALBOCICLIB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150203", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-02-06DayDUTREBISFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA206510", "applicant_as_listed_by_fda": "MERCK SHARP DOHME", "brand_names": ["DUTREBIS"], "active_ingredients": ["LAMIVUDINE", "RALTEGRAVIR POTASSIUM"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150206", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-02-13DayLENVIMAFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA206947", "applicant_as_listed_by_fda": "EISAI INC", "brand_names": ["LENVIMA"], "active_ingredients": ["LENVATINIB MESYLATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150213", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-02-23DayFARYDAKFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA205353", "applicant_as_listed_by_fda": "SECURA", "brand_names": ["FARYDAK"], "active_ingredients": ["PANOBINOSTAT LACTATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150223", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-02-25DayAVYCAZFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA206494", "applicant_as_listed_by_fda": "ABBVIE", "brand_names": ["AVYCAZ"], "active_ingredients": ["AVIBACTAM SODIUM", "CEFTAZIDIME"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150225", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-02-25DayTOUJEO SOLOSTARFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA206538", "applicant_as_listed_by_fda": "SANOFI US SERVICES", "brand_names": ["TOUJEO MAX SOLOSTAR", "TOUJEO SOLOSTAR"], "active_ingredients": ["INSULIN GLARGINE RECOMBINANT"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150225", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-02-25DayTOUJEO MAX SOLOSTARFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA206538", "applicant_as_listed_by_fda": "SANOFI US SERVICES", "brand_names": ["TOUJEO MAX SOLOSTAR", "TOUJEO SOLOSTAR"], "active_ingredients": ["INSULIN GLARGINE RECOMBINANT"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150225", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-02-26DayLILETTAFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA206229", "applicant_as_listed_by_fda": "MEDICINES360", "brand_names": ["LILETTA"], "active_ingredients": ["LEVONORGESTREL"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150226", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-03-06DayCRESEMBAFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA207500", "applicant_as_listed_by_fda": "ASTELLAS", "brand_names": ["CRESEMBA"], "active_ingredients": ["ISAVUCONAZONIUM SULFATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150306", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-03-06DayZARXIOFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA125553", "applicant_as_listed_by_fda": "SANDOZ INC", "brand_names": ["ZARXIO"], "active_ingredients": ["FILGRASTIM-SNDZ"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150306", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-03-10DayUNITUXINFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA125516", "applicant_as_listed_by_fda": "UNITED THERAP", "brand_names": ["UNITUXIN"], "active_ingredients": ["DINUTUXIMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150310", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-03-17DayCholic acidFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA205750", "applicant_as_listed_by_fda": "MIRUM", "brand_names": ["CHOLBAM"], "active_ingredients": ["CHOLIC ACID"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150317", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-03-17DayCholic AcidFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA205750", "applicant_as_listed_by_fda": "MIRUM", "brand_names": ["CHOLBAM"], "active_ingredients": ["CHOLIC ACID"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150317", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-03-17DayCHOLBAMFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA205750", "applicant_as_listed_by_fda": "MIRUM", "brand_names": ["CHOLBAM"], "active_ingredients": ["CHOLIC ACID"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150317", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-03-26DayORALTAGFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA205383", "applicant_as_listed_by_fda": "INTERPHARMA PRAHA AS", "brand_names": ["ORALTAG"], "active_ingredients": ["IOHEXOL"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150326", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-03-30DayJADENUFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA206910", "applicant_as_listed_by_fda": "NOVARTIS PHARMS CORP", "brand_names": ["JADENU"], "active_ingredients": ["DEFERASIROX"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150330", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-03-31DayPROAIR RESPICLICKFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA205636", "applicant_as_listed_by_fda": "TEVA BRANDED PHARM", "brand_names": ["PROAIR DIGIHALER", "PROAIR RESPICLICK"], "active_ingredients": ["ALBUTEROL SULFATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150331", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-03-31DayPROAIR DIGIHALERFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA205636", "applicant_as_listed_by_fda": "TEVA BRANDED PHARM", "brand_names": ["PROAIR DIGIHALER", "PROAIR RESPICLICK"], "active_ingredients": ["ALBUTEROL SULFATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150331", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-04-17DayAPTENSIO XRFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA205831", "applicant_as_listed_by_fda": "RHODES PHARMS", "brand_names": ["APTENSIO XR"], "active_ingredients": ["METHYLPHENIDATE HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150417", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-04-29DayKYBELLAFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA206333", "applicant_as_listed_by_fda": "ABBVIE", "brand_names": ["KYBELLA"], "active_ingredients": ["DEOXYCHOLIC ACID"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150429", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-04-30DayTUZISTRA XRFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA207768", "applicant_as_listed_by_fda": "TRIS PHARMA INC", "brand_names": ["TUZISTRA XR"], "active_ingredients": ["CHLORPHENIRAMINE POLISTIREX", "CODEINE POLISTIREX"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150430", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-05-14DayFLOWTUSSFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA022424", "applicant_as_listed_by_fda": "CHARTWELL RX", "brand_names": ["FLOWTUSS"], "active_ingredients": ["GUAIFENESIN", "HYDROCODONE BITARTRATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150514", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-05-14DayHYCOFENIXFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA022279", "applicant_as_listed_by_fda": "CHARTWELL RX", "brand_names": ["HYCOFENIX"], "active_ingredients": ["GUAIFENESIN", "HYDROCODONE BITARTRATE", "PSEUDOEPHEDRINE HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150514", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-05-18DayINVEGA HAFYERAFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA207946", "applicant_as_listed_by_fda": "JANSSEN PHARMS", "brand_names": ["INVEGA HAFYERA", "INVEGA TRINZA"], "active_ingredients": ["PALIPERIDONE PALMITATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150518", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-05-18DayINVEGA TRINZAFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA207946", "applicant_as_listed_by_fda": "JANSSEN PHARMS", "brand_names": ["INVEGA HAFYERA", "INVEGA TRINZA"], "active_ingredients": ["PALIPERIDONE PALMITATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150518", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-05-21DaySTIOLTO RESPIMATFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA206756", "applicant_as_listed_by_fda": "BOEHRINGER INGELHEIM", "brand_names": ["STIOLTO RESPIMAT"], "active_ingredients": ["OLODATEROL HYDROCHLORIDE", "TIOTROPIUM BROMIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150521", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-05-27DayVIBERZIFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA206940", "applicant_as_listed_by_fda": "ABBVIE", "brand_names": ["VIBERZI"], "active_ingredients": ["ELUXADOLINE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150527", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-06-22DayTUXARIN ERFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA206323", "applicant_as_listed_by_fda": "MAINPOINTE", "brand_names": ["TUXARIN ER"], "active_ingredients": ["CHLORPHENIRAMINE MALEATE", "CODEINE PHOSPHATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150622", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-06-22DayKENGREALFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA204958", "applicant_as_listed_by_fda": "CHIESI", "brand_names": ["KENGREAL"], "active_ingredients": ["CANGRELOR"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150622", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-07-02DayORKAMBIFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA206038", "applicant_as_listed_by_fda": "VERTEX PHARMS INC", "brand_names": ["ORKAMBI"], "active_ingredients": ["IVACAFTOR", "LUMACAFTOR"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150702", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-07-07DayENTRESTOFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA207620", "applicant_as_listed_by_fda": "NOVARTIS PHARMS CORP", "brand_names": ["ENTRESTO"], "active_ingredients": ["SACUBITRIL", "VALSARTAN"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150707", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-07-10DayENVARSUS XRFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA206406", "applicant_as_listed_by_fda": "VELOXIS PHARMS INC", "brand_names": ["ENVARSUS XR"], "active_ingredients": ["TACROLIMUS"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150710", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-07-10DayREXULTIFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA205422", "applicant_as_listed_by_fda": "OTSUKA", "brand_names": ["REXULTI"], "active_ingredients": ["BREXPIPRAZOLE"], "submission_type": "ORIG", "submission_number": "2", "submission_status": "AP", "submission_status_date": "20150710", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-07-15DayEPIDUO FORTEFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA207917", "applicant_as_listed_by_fda": "GALDERMA LABS", "brand_names": ["EPIDUO FORTE"], "active_ingredients": ["ADAPALENE", "BENZOYL PEROXIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150715", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-07-24DayTECHNIVIEFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA207931", "applicant_as_listed_by_fda": "ABBVIE", "brand_names": ["TECHNIVIE"], "active_ingredients": ["OMBITASVIR", "PARITAPREVIR", "RITONAVIR"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150724", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-07-24DayDAKLINZAFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA206843", "applicant_as_listed_by_fda": "BRISTOL-MYERS SQUIBB", "brand_names": ["DAKLINZA"], "active_ingredients": ["DACLATASVIR DIHYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150724", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-07-24DayODOMZOFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA205266", "applicant_as_listed_by_fda": "SUN PHARM", "brand_names": ["ODOMZO"], "active_ingredients": ["SONIDEGIB PHOSPHATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150724", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-07-24DayPRALUENTFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA125559", "applicant_as_listed_by_fda": "REGENERON PHARMACEUTICALS", "brand_names": ["PRALUENT"], "active_ingredients": ["ALIROCUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150724", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-07-31DaySPRITAMFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA207958", "applicant_as_listed_by_fda": "APRECIA PHARMS", "brand_names": ["SPRITAM"], "active_ingredients": ["LEVETIRACETAM"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150731", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-08-18DayADDYIFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA022526", "applicant_as_listed_by_fda": "SPROUT PHARMS", "brand_names": ["ADDYI"], "active_ingredients": ["FLIBANSERIN"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150818", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-08-24DayPROMACTA KITFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA207027", "applicant_as_listed_by_fda": "NOVARTIS", "brand_names": ["PROMACTA KIT"], "active_ingredients": ["ELTROMBOPAG OLAMINE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150824", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-08-26DaySYNJARDYFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA206111", "applicant_as_listed_by_fda": "BOEHRINGER INGELHEIM", "brand_names": ["SYNJARDY"], "active_ingredients": ["EMPAGLIFLOZIN", "METFORMIN HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150826", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-08-27DayREPATHAFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA125522", "applicant_as_listed_by_fda": "AMGEN INC", "brand_names": ["REPATHA"], "active_ingredients": ["EVOLOCUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150827", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-09-01DayVARUBIFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA206500", "applicant_as_listed_by_fda": "TERSERA", "brand_names": ["VARUBI"], "active_ingredients": ["ROLAPITANT HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150901", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-09-04DayXURIDENFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA208169", "applicant_as_listed_by_fda": "BTG INTL", "brand_names": ["XURIDEN"], "active_ingredients": ["URIDINE TRIACETATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150904", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-09-04DayDURLAZAFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA200671", "applicant_as_listed_by_fda": "HESP", "brand_names": ["DURLAZA"], "active_ingredients": ["ASPIRIN"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150904", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-09-17DayVRAYLARFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA204370", "applicant_as_listed_by_fda": "ABBVIE", "brand_names": ["VRAYLAR"], "active_ingredients": ["CARIPRAZINE HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150917", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-09-18DayTOLAKFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA022259", "applicant_as_listed_by_fda": "HILL DERMACEUTICALS", "brand_names": ["TOLAK"], "active_ingredients": ["FLUOROURACIL"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150918", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-09-22DayLONSURFFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA207981", "applicant_as_listed_by_fda": "TAIHO ONCOLOGY", "brand_names": ["LONSURF"], "active_ingredients": ["TIPIRACIL HYDROCHLORIDE", "TRIFLURIDINE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150922", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-09-25DayTRESIBAFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA203314", "applicant_as_listed_by_fda": "NOVO", "brand_names": ["TRESIBA"], "active_ingredients": ["INSULIN DEGLUDEC"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150925", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-09-25DayRYZODEG 70/30FDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA203313", "applicant_as_listed_by_fda": "NOVO", "brand_names": ["RYZODEG 70/30"], "active_ingredients": ["INSULIN ASPART", "INSULIN DEGLUDEC"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150925", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-10-02DayMORPHABOND ERFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA206544", "applicant_as_listed_by_fda": "OHEMO LIFE", "brand_names": ["MORPHABOND ER"], "active_ingredients": ["MORPHINE SULFATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151002", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-10-05DayARISTADAFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA207533", "applicant_as_listed_by_fda": "ALKERMES INC", "brand_names": ["ARISTADA"], "active_ingredients": ["ARIPIPRAZOLE LAUROXIL"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151005", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-10-16DayENSTILARFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA207589", "applicant_as_listed_by_fda": "LEO PHARMA AS", "brand_names": ["ENSTILAR"], "active_ingredients": ["BETAMETHASONE DIPROPIONATE", "CALCIPOTRIENE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151016", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-10-16DayPRAXBINDFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761025", "applicant_as_listed_by_fda": "BOEHRINGER INGELHEIM", "brand_names": ["PRAXBIND"], "active_ingredients": ["IDARUCIZUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151016", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-10-19DayDYANAVEL XRFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA208147", "applicant_as_listed_by_fda": "TRIS PHARMA INC", "brand_names": ["DYANAVEL XR"], "active_ingredients": ["AMPHETAMINE", "AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151019", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-10-21DayVELTASSAFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA205739", "applicant_as_listed_by_fda": "VIFOR PHARMA", "brand_names": ["VELTASSA"], "active_ingredients": ["PATIROMER SORBITEX CALCIUM"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151021", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-10-22DayONIVYDEFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA207793", "applicant_as_listed_by_fda": "IPSEN", "brand_names": ["ONIVYDE"], "active_ingredients": ["IRINOTECAN HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151022", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-10-22DayVIVLODEXFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA207233", "applicant_as_listed_by_fda": "ICEUTICA OPERATIONS", "brand_names": ["VIVLODEX"], "active_ingredients": ["MELOXICAM"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151022", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-10-23DayTrabectedinFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA207953", "applicant_as_listed_by_fda": "JANSSEN PRODS", "brand_names": ["YONDELIS"], "active_ingredients": ["TRABECTEDIN"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151023", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-10-23DayYONDELISFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA207953", "applicant_as_listed_by_fda": "JANSSEN PRODS", "brand_names": ["YONDELIS"], "active_ingredients": ["TRABECTEDIN"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151023", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-10-23DayBELBUCAFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA207932", "applicant_as_listed_by_fda": "BDSI", "brand_names": ["BELBUCA"], "active_ingredients": ["BUPRENORPHINE HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151023", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-10-23DaySTRENSIQFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA125513", "applicant_as_listed_by_fda": "ALEXION PHARM", "brand_names": ["STRENSIQ"], "active_ingredients": ["ASFOTASE ALFA"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151023", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-10-29DayUTIBRON NEOHALERFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA207930", "applicant_as_listed_by_fda": "NOVARTIS", "brand_names": ["UTIBRON NEOHALER"], "active_ingredients": ["GLYCOPYRROLATE", "INDACATEROL MALEATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151029", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-10-29DaySEEBRI NEOHALERFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA207923", "applicant_as_listed_by_fda": "NOVARTIS", "brand_names": ["SEEBRI NEOHALER"], "active_ingredients": ["GLYCOPYRROLATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151029", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-11-04DayNUCALAFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA125526", "applicant_as_listed_by_fda": "GLAXOSMITHKLINE LLC", "brand_names": ["NUCALA"], "active_ingredients": ["MEPOLIZUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151104", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-11-05DayGENVOYAFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA207561", "applicant_as_listed_by_fda": "GILEAD SCIENCES INC", "brand_names": ["GENVOYA"], "active_ingredients": ["COBICISTAT", "ELVITEGRAVIR", "EMTRICITABINE", "TENOFOVIR ALAFENAMIDE FUMARATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151105", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-11-10DayCOTELLICFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA206192", "applicant_as_listed_by_fda": "GENENTECH INC", "brand_names": ["COTELLIC"], "active_ingredients": ["COBIMETINIB FUMARATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151110", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-11-13DayTAGRISSOFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA208065", "applicant_as_listed_by_fda": "ASTRAZENECA", "brand_names": ["TAGRISSO"], "active_ingredients": ["OSIMERTINIB MESYLATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151113", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-11-16DayDARZALEXFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761036", "applicant_as_listed_by_fda": "JANSSEN BIOTECH", "brand_names": ["DARZALEX"], "active_ingredients": ["DARATUMUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151116", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-11-20DayNINLAROFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA208462", "applicant_as_listed_by_fda": "TAKEDA PHARMS USA", "brand_names": ["NINLARO"], "active_ingredients": ["IXAZOMIB CITRATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151120", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-11-24DayPORTRAZZAFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA125547", "applicant_as_listed_by_fda": "ELI LILLY CO", "brand_names": ["PORTRAZZA"], "active_ingredients": ["NECITUMUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151124", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-11-30DayEMPLICITIFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761035", "applicant_as_listed_by_fda": "BRISTOL MYERS SQUIBB", "brand_names": ["EMPLICITI"], "active_ingredients": ["ELOTUZUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151130", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-12-04DayQUILLICHEW ERFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA207960", "applicant_as_listed_by_fda": "NEXTWAVE PHARMS", "brand_names": ["QUILLICHEW ER"], "active_ingredients": ["METHYLPHENIDATE HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151204", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-12-07DayBENDEKAFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA208194", "applicant_as_listed_by_fda": "EAGLE PHARMS", "brand_names": ["BENDEKA"], "active_ingredients": ["BENDAMUSTINE HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151207", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-12-08DayKANUMAFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA125561", "applicant_as_listed_by_fda": "ALEXION PHARM", "brand_names": ["KANUMA"], "active_ingredients": ["SEBELIPASE ALFA"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151208", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-12-10DayOTIPRIOFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA207986", "applicant_as_listed_by_fda": "ALK ABELLO", "brand_names": ["OTIPRIO"], "active_ingredients": ["CIPROFLOXACIN"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151210", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

2015-12-11DayALECENSAFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA208434", "applicant_as_listed_by_fda": "HOFFMANN-LA ROCHE", "brand_names": ["ALECENSA"], "active_ingredients": ["ALECTINIB HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20151211", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026

Which sources have been checked?

We check SEC filings for company announcements and FDA sources for decisions and notices. Events without a clear match to a company or drug in our database stay unpublished. Scan dates show when checks last ran, not complete coverage.

Company-disclosed PDUFA dates (SEC)
Last completed scan: 14 Nov 2026, 17:11 UTC. Latest attempt failed; coverage may be delayed.
CDER original approvals
Last completed scan: 18 Nov 2026, 20:10 UTC.
CDER approval history (Drugs@FDA)
Last completed scan: 16 Nov 2026, 20:40 UTC.
CBER original approvals
Last completed scan: 03 Nov 2026, 21:10 UTC.
FDA complete response letters
Last completed scan: 17 Nov 2026, 22:10 UTC.
FDA advisory committee notices
Last completed scan: 06 Oct 2026, 23:10 UTC.

If a source gives only a month, quarter or year, we show that rather than an exact day. Learn about our sources

Background: what a PDUFA date is and what a complete response letter is.

Use these dates elsewhere: embed the calendar on your site or read it through the API.

PDUFA dates and the FDA calendar explained

What is a PDUFA date?

A PDUFA date is the target date by which the FDA aims to act on a new drug or biologics application under the Prescription Drug User Fee Act. Standard reviews target about ten months and priority reviews about six. Companies usually disclose the date in a press release or SEC filing once the FDA accepts the application. PDUFA target action date in the glossary

Is a PDUFA date the same as the FDA approval date?

No. The PDUFA date is when the FDA aims to finish its review. On or before that date the agency can approve the application, issue a complete response letter or extend the goal date. This calendar lists PDUFA dates and published FDA decisions as separate event types.

Where do the dates in this FDA calendar come from?

PDUFA dates come from company filings with the US Securities and Exchange Commission. Approval decisions, complete response letters and advisory committee meetings come from FDA publications and Federal Register notices. Every entry links to the source it was taken from.

What happens when a PDUFA date changes?

When a company discloses a revised goal date, the calendar shows the new date and the drug page keeps the earlier date with its source.

How do I add PDUFA dates to my own calendar?

Subscribe to the FDA calendar feed in Google Calendar, Apple Calendar or Outlook using the link on this page. The feed carries upcoming and recent published events reported with an exact day. FDA calendar feed (.ics)